About
Navina builds an AI clinical copilot and intelligence platform for value-based healthcare organizations, including provider groups, health systems, and health plans. Its platform combines EHR, HIE, claims, and other clinical data into actionable patient profiles, evidence-backed recommendations, risk-adjustment insights, and care-gap workflows integrated into clinicians’ existing processes.
Market
Navina competes in healthcare AI and value-based-care technology, combining clinical intelligence, risk adjustment, quality management, analytics, and point-of-care workflow support. It positions itself as a clinician-first, EHR-integrated layer that reconciles fragmented EHR, HIE, claims, and ambient data into actionable insights, differentiating through evidence-backed recommendations, explainable AI, and workflow-native documentation rather than relying primarily on retrospective analytics or back-office processes.
Navina primarily serves value-based healthcare organizations, including provider groups, ACOs, health systems, and other organizations managing risk adjustment, quality performance, and care-gap closure. Its users and likely buying stakeholders include physicians, care teams, clinical operations leaders, and value-based-care or coding executives.
At a Glance
Problem
Value-based-care organizations must turn fragmented clinical information into timely, documented action. Relevant evidence is spread across EHR notes and imaging, claims, health-information exchanges, and other unstructured records, creating administrative work for clinicians and back-office teams while making care-gap closure and risk adjustment harder. The economic pain is reflected in quality and HEDIS performance, reimbursement, and the cost of retrospective chart review. Navina’s central use cases are surfacing missed conditions for risk adjustment and identifying care gaps at the point of care so providers can improve quality performance while reducing manual effort.
Product / Service
Navina provides an AI-powered clinical-intelligence platform and clinician copilot for value-based care. Its software aggregates complex data across EHRs, HIEs, claims, notes, and imaging, then converts it into evidence-backed clinical insights. In risk adjustment, it recommends newly suspected conditions and supports HCC documentation; in quality management, it extracts information from buried documents to identify care gaps and alert providers.
The product is designed to fit existing workflows rather than create a separate review process. It operates natively in the EHR, integrates bidirectionally with patient records, and enables one-click documentation. The intended benefit is higher clinician adoption and trust, less administrative burden, better risk-adjustment accuracy, and more proactive quality-care-gap closure.
Market
Navina competes in healthcare AI, clinical intelligence, and digital workflow software for value-based care, particularly risk adjustment, quality management, and point-of-care decision support. The reviewed company materials do not name specific competitors; they position Navina instead as a clinician-first AI copilot and cite organizations such as Privia Health, Agilon Health, Innovacare Health, Upperline Health, and others as customers or trusted users.
The company is clearly commercial rather than pre-revenue. Navina reports a $55 million Series C completed in March 2026, bringing total funding to $100 million, and its site says the copilot ranked #1 in the 2025 Best in KLAS Clinician Digital Workflow category. Reported customer outcomes include a 12% boost in quality metrics for a multi-state primary-care provider, 97% clinician adoption and 41% more conditions surfaced at Upperline Health, and quality-measure performance improvements of up to 24% for partners using its quality-management platform.
Founders & Leadership
Funding History
Grove Ventures
Vertex Ventures Israel
ALIVE Israel HealthTech Fund
Growth Equity at Goldman Sachs Alternatives
Recent News
Former Humana CEO Bruce Broussard joined Navina’s advisory board. His experience in Medicare Advantage and integrated care models is expected to support Navina’s expansion across providers and health plans.
Summit Health is deploying Navina’s AI tool to help clinicians understand patient health status, close care gaps, and reduce administrative burden. The initial implementation onboarded more than 1,000 providers, coders, and quality-care team members, with integration into Summit Health’s electronic health record.
Navina announced a $55 million Series C round led by Growth Equity at Goldman Sachs Alternatives, bringing total funding to $100 million. The investment is intended to accelerate U.S. expansion, proprietary AI development, and workflow automation across value-based care.
Active Roles
3Business Model
Navina operates as an enterprise digital-health SaaS company, selling its AI copilot and clinical intelligence platform to value-based-care organizations and other healthcare enterprises. Its website directs prospective customers to book a strategy call rather than publishing prices, indicating a sales-led, negotiated enterprise model; public pricing details were not found.
Products
Customers
Tech Stack
Similar Companies
Competitors
Key Investors
Goldman Sachs Growth Equity, Vertex Ventures Israel, Grove Ventures, ALIVE Israel HealthTech Fund